{"id":"https://openalex.org/W2209229458","doi":"https://doi.org/10.2119/2007-00008.villa","title":"The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats","display_name":"The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats","alternate_titles":[],"publication_year":2007,"publication_date":"2007-03-01","ids":{"openalex":"https://openalex.org/W2209229458","doi":"https://doi.org/10.2119/2007-00008.villa","mag":"2209229458","pmid":"https://pubmed.ncbi.nlm.nih.gov/17592546","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1892761"},"language":"en","primary_location":{"id":"doi:10.2119/2007-00008.villa","doi":"https://doi.org/10.2119/2007-00008.villa","is_oa":true,"landing_page_url":"https://doi.org/10.2119/2007-00008.villa","pdf_url":"https://molmed.biomedcentral.com/counter/pdf/10.2119/2007-00008.Villa","source":{"id":"https://openalex.org/S6769275","display_name":"Molecular Medicine","issn_l":"1076-1551","issn":["1076-1551","1528-3658"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2209229458"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://molmed.biomedcentral.com/counter/pdf/10.2119/2007-00008.Villa","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Pia Villa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pia Villa","raw_affiliation_strings":["CNR, Institute of Neuroscience, 20129, Milan, Italy","Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNR, Institute of Neuroscience, 20129, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041365213","display_name":"Sara Triulzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sara Triulzi","raw_affiliation_strings":["Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012265959","display_name":"Barbara Cavalieri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barbara Cavalieri","raw_affiliation_strings":["Domp\u00e9 pha.r.ma s.p.a., 67100, L\u2019Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 pha.r.ma s.p.a., 67100, L\u2019Aquila, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028613021","display_name":"Rosa Di Bitondo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rosa Di Bitondo","raw_affiliation_strings":["Domp\u00e9 pha.r.ma s.p.a., 67100, L\u2019Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 pha.r.ma s.p.a., 67100, L\u2019Aquila, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107947729","display_name":"Riccardo Bertini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Riccardo Bertini","raw_affiliation_strings":["Domp\u00e9 pha.r.ma s.p.a., 67100, L\u2019Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Domp\u00e9 pha.r.ma s.p.a., 67100, L\u2019Aquila, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077803960","display_name":"Sara Barbera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sara Barbera","raw_affiliation_strings":["Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079597058","display_name":"Paolo Bigini","orcid":"https://orcid.org/0000-0002-0239-9532","observed_orcids":["https://orcid.org/0000-0002-0239-9532"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paolo Bigini","raw_affiliation_strings":["Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072158250","display_name":"Tiziana Mennini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tiziana Mennini","raw_affiliation_strings":["Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051468925","display_name":"Paolo Gelosa","orcid":"https://orcid.org/0000-0003-4442-537X","observed_orcids":["https://orcid.org/0000-0003-4442-537X"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paolo Gelosa","raw_affiliation_strings":["Department of Pharmacological Sciences, University of Milan, 20133, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, University of Milan, 20133, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004341489","display_name":"Elena Tremoli","orcid":"https://orcid.org/0000-0002-0929-6106","observed_orcids":["https://orcid.org/0000-0002-0929-6106"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210089474","display_name":"Centro Cardiologico Monzino","ror":"https://ror.org/006pq9r08","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210089474","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elena Tremoli","raw_affiliation_strings":["Centro Cardiologico Monzino, IRCCS, 20138, Milan, Italy","Department of Pharmacological Sciences, University of Milan, 20133, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Cardiologico Monzino, IRCCS, 20138, Milan, Italy","institution_ids":["https://openalex.org/I4210089474"]},{"raw_affiliation_string":"Department of Pharmacological Sciences, University of Milan, 20133, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041137998","display_name":"Luigi Sironi","orcid":"https://orcid.org/0000-0002-4738-3454","observed_orcids":["https://orcid.org/0000-0002-4738-3454"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luigi Sironi","raw_affiliation_strings":["Department of Pharmacological Sciences, University of Milan, 20133, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, University of Milan, 20133, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049977155","display_name":"Pietro Ghezzi","orcid":"https://orcid.org/0000-0003-0911-8358","observed_orcids":["https://orcid.org/0000-0003-0911-8358"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Pietro Ghezzi","raw_affiliation_strings":["Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Neuroimmunology, Mario Negri Institute, via Eritrea 62, 20157, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5049977155"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":3.2555,"has_fulltext":true,"cited_by_count":96,"citation_normalized_percentile":{"value":0.91225635,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"13","issue":"3-4","first_page":"125","last_page":"133"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.6416000127792358,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.6416000127792358,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.2354000061750412,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.06790000200271606,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/reparixin","display_name":"reparixin","score":0.996999979019165},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cerebral-ischemia","display_name":"cerebral ischemia","score":0.8849999904632568},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9330000281333923},{"id":"https://openalex.org/keywords/transient-ischemia","display_name":"transient ischemia","score":0.7789999842643738},{"id":"https://openalex.org/keywords/neutrophil-infiltration","display_name":"neutrophil infiltration","score":0.777999997138977},{"id":"https://openalex.org/keywords/leukocyte-infiltration","display_name":"leukocyte infiltration","score":0.8619999885559082},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.8949999809265137},{"id":"https://openalex.org/keywords/neurological-deficit","display_name":"neurological deficit","score":0.8080000281333923},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.5429999828338623},{"id":"https://openalex.org/keywords/treatment-schedule","display_name":"treatment schedule","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7707371711730957},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.7367451190948486},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.6479157209396362},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.6314771175384521},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.45949462056159973},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4375258982181549},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4375104010105133},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4170994460582733},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32761746644973755},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3143436014652252},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30056071281433105},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2812907099723816},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002546","descriptor_name":"Ischemic Attack, Transient","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002546","descriptor_name":"Ischemic Attack, Transient","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002546","descriptor_name":"Ischemic Attack, Transient","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053700","descriptor_name":"Receptors, Interleukin-8","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.2119/2007-00008.villa","doi":"https://doi.org/10.2119/2007-00008.villa","is_oa":true,"landing_page_url":"https://doi.org/10.2119/2007-00008.villa","pdf_url":"https://molmed.biomedcentral.com/counter/pdf/10.2119/2007-00008.Villa","source":{"id":"https://openalex.org/S6769275","display_name":"Molecular Medicine","issn_l":"1076-1551","issn":["1076-1551","1528-3658"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1892761","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1892761/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Med","raw_type":"Text"},{"id":"pmid:17592546","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17592546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular medicine (Cambridge, Mass.)","raw_type":"Comparative Study"},{"id":"pmh:oai:ora.uniurb.it:11576/2713516","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11576/2713516","pdf_url":null,"source":{"id":"https://openalex.org/S4377196377","display_name":"CINECA IRIS Institutional Research information system (University of Urbino)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I190397597","host_organization_name":"University of Urbino","host_organization_lineage":["https://openalex.org/I190397597"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2119/2007-00008.villa","doi":"https://doi.org/10.2119/2007-00008.villa","is_oa":true,"landing_page_url":"https://doi.org/10.2119/2007-00008.villa","pdf_url":"https://molmed.biomedcentral.com/counter/pdf/10.2119/2007-00008.Villa","source":{"id":"https://openalex.org/S6769275","display_name":"Molecular Medicine","issn_l":"1076-1551","issn":["1076-1551","1528-3658"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2209229458.pdf","grobid_xml":"https://content.openalex.org/works/W2209229458.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1967501877","https://openalex.org/W1968128770","https://openalex.org/W1974135000","https://openalex.org/W1981724301","https://openalex.org/W1983033348","https://openalex.org/W2004189343","https://openalex.org/W2005540677","https://openalex.org/W2010461736","https://openalex.org/W2013603704","https://openalex.org/W2020500819","https://openalex.org/W2026983332","https://openalex.org/W2039100774","https://openalex.org/W2046529212","https://openalex.org/W2048431655","https://openalex.org/W2054552572","https://openalex.org/W2065534101","https://openalex.org/W2068210940","https://openalex.org/W2070193696","https://openalex.org/W2071646614","https://openalex.org/W2077476545","https://openalex.org/W2084899362","https://openalex.org/W2088557737","https://openalex.org/W2111779594","https://openalex.org/W2115741342","https://openalex.org/W2118403271","https://openalex.org/W2122965222","https://openalex.org/W2125683177","https://openalex.org/W2125691088","https://openalex.org/W2136836360","https://openalex.org/W2140538238","https://openalex.org/W2141580911","https://openalex.org/W2141624030","https://openalex.org/W2142463112","https://openalex.org/W2143708434","https://openalex.org/W2148809826","https://openalex.org/W2151400960","https://openalex.org/W2155885439","https://openalex.org/W2155987479","https://openalex.org/W2167915117","https://openalex.org/W2408296410"],"related_works":["https://openalex.org/W2146361708","https://openalex.org/W2004189343","https://openalex.org/W4230405497","https://openalex.org/W2896230971","https://openalex.org/W2137739272","https://openalex.org/W2031981320","https://openalex.org/W3008220567","https://openalex.org/W348277772","https://openalex.org/W2187001175","https://openalex.org/W4282913331"],"abstract_inverted_index":{"Leukocyte":[0],"infiltration":[1],"is":[2,107],"viewed":[3],"as":[4],"a":[5,16,32,116,140],"pharmacological":[6],"target":[7],"in":[8,31,52,110,118,133],"cerebral":[9,38],"ischemia.":[10],"We":[11],"previously":[12],"reported":[13],"that":[14,20,126],"reparixin,":[15],"CXCL8":[17],"receptor":[18],"blocker":[19],"inhibits":[21,93],"neutrophil":[22],"infiltration,":[23],"and":[24,54,61,71,92,136],"related":[25],"molecules":[26],"can":[27],"reduce":[28],"infarct":[29,97,122],"size":[30,98,123],"rat":[33],"model":[34],"of":[35,50,121],"transient":[36,53,111],"middle":[37],"artery":[39],"occlusion":[40],"(MCAO).":[41],"The":[42,96],"study":[43],"aims":[44],"were":[45],"to":[46,64,79,83],"compare":[47],"the":[48,119],"effects":[49,66],"reparixin":[51,125],"permanent":[55,134],"MCAO":[56],"using":[57],"varied":[58],"treatment":[59],"schedules":[60],"therapeutic":[62],"windows":[63],"evaluate":[65],"on":[67],"long-term":[68,94,145],"neurological":[69,89,146],"deficits":[70],"late":[72],"inflammatory":[73],"response.":[74],"Reparixin,":[75],"administered":[76],"for":[77],"1":[78],"3":[80],"days,":[81],"3.5":[82],"6":[84],"h":[85,132],"after":[86],"MCAO,":[87,135],"ameliorates":[88],"function":[90],"recovery":[91,143],"inflammation.":[95],"reduction":[99],"at":[100,130],"24":[101],"h,":[102],"evaluated":[103],"by":[104,124],"TTC":[105],"staining,":[106],"more":[108,128],"pronounced":[109],"MCAO.":[112],"MRI":[113],"analysis":[114],"identified":[115],"decrease":[117],"progression":[120],"was":[127,137],"evident":[129],"48":[131],"associated":[138],"with":[139],"significantly":[141],"improved":[142],"from":[144],"deficits.":[147]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2209229458","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
